|2005N-0354||Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing|
|FDA Comment Number :||EC27|
|Submitter :||Mr. Anna Hazelton||Date & Time:||11/18/2005 02:11:40|
|Organization :||Mr. Anna Hazelton|
|Category :||Drug Industry|
| Please hold the SSRI antidepressant industry accountable for misleading ads calling depression a 'chemical imbalance.' There is very little evidence that this claim is true. In most studies SSRIs have done only slightly better than placebo. These companies should not get away with shady advertising simply because their product is connected with psychiatry, as opposed to any other branch of medicine.
Thanks for your time.